Geneva, June 4 -- International Clinical Trials Registry received information related to the study (TCTR20250522005) titled 'Effectiveness of palliative re-irradiation with superficial hyperthermia in patients with unresectable recurrent squamous cell carcinoma of the head and neck' on May 22.
Study Type: Interventional
Study Design:
N/A
Primary Sponsor: ABEX global healthcare,Thailand
Condition:
Adverse effects will be evaluated using physical examination according to the RTOG toxicity score, specifically for radiation-induced dermatitis. Pain will be assessed using a visual analog scale (VAS), and quality of life will be assessed using the EQ-5D-5L Thai version questionnaire.
dermatitis, hyperthermia, re-irradiation
dermatitis, h...